Intelligent Bio Solutions
INBS
8 hedge funds and large institutions have $108K invested in Intelligent Bio Solutions in 2024 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 0 reducing their positions, and 3 closing their positions.
0% more funds holding
Funds holding: 8 → 8 (0)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
0.42% less ownership
Funds ownership: 0.59% → 0.18% (-0.42%)
75% less capital invested
Capital invested by funds: $437K → $108K (-$329K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
+$23.5K |
| 2 |
GSC
Ground Swell Capital
Folly Beach,
South Carolina
|
+$15.9K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$7.23K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$5.93K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$2.06K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
-$357K |
| 2 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
-$9.32K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Geode Capital Management
Boston,
Massachusetts
| $37.2K | +$5.93K | +389 | +17% |
|
2
Vanguard Group
Malvern,
Pennsylvania
| $21.7K | – | – | – |
|
|
TSS
3
Two Sigma Securities
New York
| $21.6K | +$23.5K | +1,540 | New |
|
|
GSC
4
Ground Swell Capital
Folly Beach,
South Carolina
| $14.6K | +$15.9K | +1,040 | New |
|
|
TRCT
5
Tower Research Capital (TRC)
New York
| $8.12K | +$7.23K | +474 | +447% |
|
|
6
UBS Group
Zurich,
Switzerland
| $4.06K | +$2.06K | +135 | +87% |
|
|
SS
7
SBI Securities
Tokyo,
Japan
| $281 | +$305 | +20 | New |
|
8
Bank of America
Charlotte,
North Carolina
| $50 | +$15 | +1 | +33% |
|
|
9
Alyeska Investment Group
Chicago,
Illinois
| – | -$357K | -20,620 | Closed |
|
|
ACM
10
ADAR1 Capital Management
Austin,
Texas
| – | -$9.32K | -539 | Closed |
|
INBS Hedge Fund Activity: Q4 2024 in Review
8 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Intelligent Bio Solutions (INBS) for Q4 2024, worth a combined $108K — down 75% from $437K a quarter earlier.
Fund positioning in INBS was balanced in Q4 2024: 3 funds opened new positions, 3 closed out, 4 added to existing stakes and 0 trimmed.
The largest buyer was Two Sigma Securities, opening a new position worth an estimated $23.5K. The largest seller was Alyeska Investment Group, exiting entirely with an estimated $357K sold.
- 8 institutional investors held Intelligent Bio Solutions (INBS) as of Q4 2024, unchanged from Q3 2024.
- Funds reported $108K of Intelligent Bio Solutions stock for Q4 2024, down 75% quarter-over-quarter.
- 3 funds opened new Intelligent Bio Solutions positions in Q4 2024 and 3 closed out, a net change of 0 holders.
- The largest Intelligent Bio Solutions buyer in Q4 2024 was Two Sigma Securities, an estimated $23.5K added.
- The largest Intelligent Bio Solutions seller in Q4 2024 was Alyeska Investment Group, an estimated $357K sold.
Based on aggregated 13F filings for Q4 2024.